These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 5033660)

  • 1. Limitations of the activated partial thromboplastin time for determination of plasma heparin concentration and half-life in human subjects.
    Baele G; De Broe M; De Weerdt GA; Ringoir S; Barbier F
    Thromb Diath Haemorrh; 1972 Feb; 27(1):107-13. PubMed ID: 5033660
    [No Abstract]   [Full Text] [Related]  

  • 2. Activated coagulation time test: a convenient monitor of heparinization for dogs used in cardiovascular research.
    Wilkerson RD; Conran PB; Greene SL
    Lab Anim Sci; 1984 Feb; 34(1):62-5. PubMed ID: 6716959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activated partial thromboplastin time and activated coagulation time in monitoring heparinized cats.
    Greene CE; Meriwether E
    Am J Vet Res; 1982 Aug; 43(8):1473-7. PubMed ID: 7103231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The activated partial thromboplastin time.
    Chin JL
    N Engl J Med; 1973 Jun; 288(26):1410. PubMed ID: 4707428
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of activated recalcification and partial thromboplastin tests as controls of heparin therapy.
    Ray PK; Harper TA
    J Lab Clin Med; 1971 Jun; 77(6):901-7. PubMed ID: 5559859
    [No Abstract]   [Full Text] [Related]  

  • 6. [Determination of activated recalcification time in thrombocyte-poor plasma].
    Kuhfahl E
    Z Med Lab Diagn; 1986; 27(8):451-7. PubMed ID: 3564626
    [No Abstract]   [Full Text] [Related]  

  • 7. [Measurement of activated whole blood coagulation as a control parameter for heparin dosage in hemodialysis].
    Kraatz G; Lopot F
    Z Urol Nephrol; 1984 Aug; 77(8):465-71. PubMed ID: 6495895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple technique for the measurement of plasma heparin concentration during anticoagulant therapy.
    Marder VJ
    Thromb Diath Haemorrh; 1970 Oct; 24(1):230-9. PubMed ID: 5483963
    [No Abstract]   [Full Text] [Related]  

  • 9. Laboratory control of heparin therapy with the activated partial thromboplastin time test.
    Degnan TJ; Karasik S; Lenahan J
    Curr Ther Res Clin Exp; 1969 Jun; 11(6):390-6. PubMed ID: 4979988
    [No Abstract]   [Full Text] [Related]  

  • 10. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma heparin: a simple, one-sample determination of both effect and concentration based on the activated partial thromboplastin time.
    Hoffman JJ; Meulendijk PN
    Clin Chim Acta; 1978 Aug; 87(3):417-24. PubMed ID: 679478
    [No Abstract]   [Full Text] [Related]  

  • 13. Activated partial thromboplastin time test in heparin therapy. A study.
    Simmons A; Cross DE
    Mo Med; 1969 Jun; 66(6):430-3. PubMed ID: 5771362
    [No Abstract]   [Full Text] [Related]  

  • 14. [The determination of heparin].
    Aiach M
    Ann Biol Clin (Paris); 1982; 40(6):645-50. PubMed ID: 7165134
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of factor XI in a dilute thromboplastin assay of extrinsic coagulation pathway.
    He R; Xiong S; He X; Liu F; Han J; Li J; He S
    Thromb Haemost; 2001 Jun; 85(6):1055-9. PubMed ID: 11434684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of heparinase to eliminate heparin inhibition in routine coagulation assays.
    Hutt ED; Kingdon HS
    J Lab Clin Med; 1972 Jun; 79(6):1027-34. PubMed ID: 5025456
    [No Abstract]   [Full Text] [Related]  

  • 17. Standardized methods for heparin therapy.
    Soloway HB
    N Engl J Med; 1973 Aug; 289(8):429-30. PubMed ID: 4719832
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of heparin therapy. Sensitivity of the activated partial thromboplastin time for monitoring the antithrombotic effects of heparin.
    Zucker S; Cathey MH
    J Lab Clin Med; 1969 Feb; 73(2):320-6. PubMed ID: 5764028
    [No Abstract]   [Full Text] [Related]  

  • 19. Circulating heparin during liver transplantation.
    Chapin JW; Peters KR; Winslow J; Becker GL; Skinner H
    Transplant Proc; 1993 Apr; 25(2):1803. PubMed ID: 8470172
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies of phospholipid reagents used in coagulation II: factors influencing their sensitivity to heparin.
    Barrowcliffe TW; Gray E
    Thromb Haemost; 1981 Oct; 46(3):634-7. PubMed ID: 7314057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.